TROMBOSİTOPENİNİN AYIRICI TANISINDA TROMBOSİT PARAMETRELERİNİN KLİNİK ÖNEMİ
Objectives: Bone Marrow (BM) examination is the gold-standard test in discriminating between hyperdestructive thrombocytopenia and hypoproductive thrombocytopenia. However, BM examination is an invasive, time-consuming, and expensive approach. Therefore, BM study is not recommended as the first-line method. Recent studies showed that platelet parameters such as mean platelet volume (MPV), plateletcrit (PCT), platelet size deviation width (PDW) could be used for differential diagnosis of thrombocytopenia. In the present study, accordingly, we aimed to investigate the significance of these parameters in the differential diagnosis of thrombocytopenia. Materials and Methods: One hundred sixty-four (164) patients with thrombocytopenia were included in the present study. The patients were divided into two groups according to the time of the diagnosis of thrombocytopenia: hyperdestructive (75 ITP) and hypoproductive (25 AA, 25 MDS, 24 AML, 15 ALL). The diagnosis was made based on hematological, pathological, and chromosomal analyses and guidelines. Samples for complete blood counts were collected in K3EDTA tubes and analyzed with an automated hematology analyzer, Beckman-Coulter. Results: The platelet count was similar in both groups. The present results showed that there were no statistically significant differences between the groups in terms of age, gender and PDW. However, MPV was significantly higher in the hyperdestructive group than the hypoproductive group. By contrast, PCT was considerably lower in the hyperdestructive group than the hypoproductive group. Conclusion: The results of the present study indicated that these platelet parameters might provide additional contributions to strengthen the diagnosis in patients diagnosed with ITP and would be beneficial to consider the thrombocyte parameters as well as the clinical and other laboratory tests of the patient.
CLINICAL SIGNIFICANCE OF PLATELET PARAMETERS IN THE DIFFERENTIAL DIAGNOSIS OF THROMBOCYTOPENIA
Objectives: Bone Marrow (BM) examination is the gold-standard test in discriminating between hyperdestructive thrombocytopenia and hypoproductive thrombocytopenia. However, BM examination is an invasive, time-consuming, and expensive approach. Therefore, BM study is not recommended as the first-line method. Recent studies showed that platelet parameters such as mean platelet volume (MPV), plateletcrit (PCT), platelet size deviation width (PDW) could be used for differential diagnosis of thrombocytopenia. In the present study, accordingly, we aimed to investigate the significance of these parameters in the differential diagnosis of thrombocytopenia. Materials and Methods: One hundred sixty-four (164) patients with thrombocytopenia were included in the present study. The patients were divided into two groups according to the time of the diagnosis of thrombocytopenia: hyperdestructive (75 ITP) and hypoproductive (25 AA, 25 MDS, 24 AML, 15 ALL). The diagnosis was made based on hematological, pathological, and chromosomal analyses and guidelines. Samples for complete blood counts were collected in K3EDTA tubes and analyzed with an automated hematology analyzer, Beckman-Coulter. Results: The platelet count was similar in both groups. The present results showed that there were no statistically significant differences between the groups in terms of age, gender and PDW. However, MPV was significantly higher in the hyperdestructive group than the hypoproductive group. By contrast, PCT was considerably lower in the hyperdestructive group than the hypoproductive group. Conclusion: The results of the present study indicated that these platelet parameters might provide additional contributions to strengthen the diagnosis in patients diagnosed with ITP and would be beneficial to consider the thrombocyte parameters as well as the clinical and other laboratory tests of the patient.
___
- 1. Numbenjapon T, Mahapo N, Pornvipavee R, et al. A prospective evaluation of normal platelet volume in discriminating hyperdestructive thrombocytopenia from hypoproductive thrombocytopenia. Int J Lab Hem 2008;30:408-14 (doi: 10.1111/j.1751-553X.2007.00969.x).
- 2. Levine SP. Thrombocytopenia pathophysiology and classification. In: Wintrobe’s Clinical Hematology, Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rogers GM(eds), 9th ed. William & Wilkins, Baltimore:1999;1579–82.
- 3. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. British Journal of Hematology 2003;120:574–96 (doi: 10.1046/j.1365- 2141.2003.04131.x).
- 4. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballen PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I. Idiopathic thrombocytopenia purpura, a practical guideline developed by explicit methods for the American Society of Hematology. Blood, 1996; 88:3–40 (doi:10.1182/blood.V88.1.3.3).
- 5. Mak YK, Yu PH, Chan CH, Chu YC. The management of isolated thrombocytopenia in Chinese adults: does bone marrow examination have a role at presentation? Clinical and Laboratory Hematology 2000; 22: 355–8 ( doi: 10.1046/j.1365-2257.2000.00340.x).
- 6. Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, Mc Can SR, Mercieca J, Oscier D, Roques AW, Yin JA. British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquired aplastic anemia. British Journal of Hematology 2003;123:782–801(doi: 10.1046/j.1365-2141.2003.04721.x).
- 7. Niethammer AG, Forman EN. Use of the platelet histogram maximum in evaluating thrombocytopenia. American Journal of Hematology 1999;60:19–23 (doi: 10.1002/(sici)1096- 8652(199901)60:1<19::aid-ajh4>3.0.co;2-1)
- 8. Kaito K, Otsubo H, Usui N, Yoshida M. Platelet size deviation width, platelet large cell ratio and mean platelet volume have sufficient sensitivity and specifity in the diagnosis of immune Thrombocytopenia. British Journal of Hematology 2005;128(5):698–702 (doi:10.1111/j.1365- 2141.2004.05357.x).
- 9. Rajantie J, Javela K, Joutsi-Korhonen L, Kekomaki R. Chronic thrombocytopenia of childhood: use of non-invasive methods in clinical evaluation. European Journal of Hematology 2004;72:268–72 (doi: 10.1111/j.1600-0609.2004.00215.x)
- 10. Ihtesham MK, Ullah I. Diagnostic importance of mean platelet volume, platelet distribution width and platelet large cell ratio as screening tool in immune thrombocytopenia. Porto Biomedical Journal 2020;24:5(6) ( doi: 10.1097/j.pbj.0000000000000094).
- 11. Bat A, Goveas A, Jayaprakash CS. Diagnostic iImplication of mean platelet volume in thrombocytopenia. Annals of Pathology and Laboatory Medicine 2020;7(2):A66-70 (doi:10.21276/APALM.2609).
- 12. Chaitra, Tejeswini V, Renuka VI, Manasa B. Role of platelet indices as a predictive tool in hypoproliferative and hyperdestructive type of thrombocytopenia. Journal of Clinical and Diagnostic Research 2020;14(3):14-17 (doi: 10.7860/JCDR/2020/43241.13568).
- 13. Francis R, Shetageri SN, Roopa AN, Parthiban SRR. A study to evaluate use of platelet indices in hyperdestructive thrombocytopenia: A two-year experience from tertiary care rural hospital. Journal of Medical Sciences and Health 2021;7(1):73-80 (doi:10.46347/jmsh.2021.v07i01.013).
- 14. Tang YT, He P, Li YZ, Chen HZ, Chang XL, Xie QD, Jiao XY. Diagnostic value of platelet indices and bone marrow megakaryocytic parameters in immune thrombocytopenic purpura. Blood Coagul Fibrinolysis . 2017 Jan ;28(1):83-90 ( doi:10.1097/MBC.612).
- 15. Gulati I, Kumar H, Sheth J, Dey I. Diagnostic implication of mean platelet volume in thrombocytopenia. Med J DY Patil Univ 2017;10: 370-5 (doi: 10.4103 MJDRDYPU. 306.16).
- 16. Lalita N,Wichan K, Ekarat R, Thanawat R, Chatree C, Adisak T. The use of mean platelet volume for distinguishing the causes of thrombocytopenia in adult patients. Hematology Reports 2019;11:7732 (doi: 10.4081/hr.2019.7732).
- 17. Islam S, Islam MS, Ahmed MU, Aziz MA, Begum M. Role of mean platelet volume (MPV), platelet distribution width (PDW) and platelet large cell ratio (P-LCR) value in the diagnosis of immune thrombocytopenic purpura. Hematol Transfus Int J 2016;2:29-31(doi: 10.1506/htij.2016.03.00031).
- 18. C handra H, Chandra S, Rawat A, Verma SK. Role of mean platelet volume as discriminating guide for bone marrow disease in patients with thrombocytopenia. Int J Lab Hematol 2010;32:498-505 (doi: 10.1111/j.1751-553X.2009.01212.x).
- 19. Reddy RS, Phansalkar MD, Ramalakshmi PV. Mean platelet volume (MPV) in thrombocytopenia. J Contemp Med Dent 2014;2:45‐50 (doi:10.18049/jcmad/229).
- 20. Pritam SK, Sarika M, Asish P, Megha P. Role of mean platelet volume (MPV) in diagnosing categories of thrombocytopenia. Indian Journal of Pathology and Oncology, October-December 2016;3(4);606- 10 (doi:10.5958/2394-6792.2016.00112.5).
- 21. Elsewefy DA, Farweez BA, Ibrahim RR. Platelet indices: Consideration in thrombocytopenia. Egypt J Hematol 2014;39:134‐8 (doi: 10.4103/1110-1067.148240).
- 22. Bhalara SK, Shah S, Goswami H, Gonsai RN. Clinical and etiological profi le of thrombocytopenia in adults: A tertiary care hospital based cross-sectional study. Int J Med Sci Public Health 2015;4:7-10 (doi: 10.5455/ijmsph.2015.060920141).
- 23. Ntaios G, Papadopoulos A, Chatzinikolaou A, Saouli Z, Karalazou P, Kaiafa G. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. Acta Hematol 2008;119:173‐7 (doi: 10.1159/000135658).
- 24. Leader A, Pereg D, Lishner M. Are platelet volume indices of clinical use? A multidisciplinary review. Ann Med 2012;44:805-16 (doi: 10.3109/07853890.2011.653391).
- 25. Negash M, Tsegaye A, Medhin AG. Diagnostic predictive value of platelet indices for discriminating hypo productive versus immune thrombocytopenia purpura in patients attending a tertiary care teaching hospital in Addis Ababa, Ethiopia. BMC Hematology 2016;16:1-8 (doi: 10.1186/s12878- 016-0057-5).
- 26. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. British Journal of Hematology 2002; 117:399–404 (doi: 10.1046/j.1365-2141.2002.03441.x ).
- 27. Henning BF, Zidek W, Linder B. ,Tepel M. Mean platelet volume and coronary heart disease in hemodialysis patients. Kidney and Blood Pressure Research 2002;25:103–8 (doi: 10.1159/000063516).
- 28. Karnad A, Poskitt TR. The automated complete blood cell count. Use of the red blood cell volume distribution width and mean platelet volume in evaluating anemia and thrombocytopenia. Archives of Internal Medicine 1985;145:1270–2 (doi: 10.1001/archinte.145.7.1270).
- 29. Gardner FH, Bessman JD. Thrombocytopenia due to defective platelet production. Hematology 1983;12:23–38 (doi: 10.1016/S0308-2261(21)00373-8).
- 30. Bowles KM, Cooke LJ, Richards EM, Baglin TP. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clinical and Laboratory Hematology 2005;27:370–3 (doi: 10.1111/j.1365- 2257.2005.00726.x).